CN100509862C - Synthesis process of beta-cyclodextrin-poly-L-glutamic acid-benzyl ester grafted copolymer - Google Patents
Synthesis process of beta-cyclodextrin-poly-L-glutamic acid-benzyl ester grafted copolymer Download PDFInfo
- Publication number
- CN100509862C CN100509862C CNB2006101347363A CN200610134736A CN100509862C CN 100509862 C CN100509862 C CN 100509862C CN B2006101347363 A CNB2006101347363 A CN B2006101347363A CN 200610134736 A CN200610134736 A CN 200610134736A CN 100509862 C CN100509862 C CN 100509862C
- Authority
- CN
- China
- Prior art keywords
- cyclodextrin
- glutamic acid
- benzyl ester
- poly
- precipitate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920001577 copolymer Polymers 0.000 title abstract description 11
- 238000000034 method Methods 0.000 title abstract description 5
- 230000015572 biosynthetic process Effects 0.000 title description 11
- 238000003786 synthesis reaction Methods 0.000 title description 11
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 41
- 239000001116 FEMA 4028 Substances 0.000 claims abstract description 40
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims abstract description 40
- 229960004853 betadex Drugs 0.000 claims abstract description 40
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims abstract description 36
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims abstract description 29
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 28
- -1 amino β-cyclodextrin Chemical compound 0.000 claims abstract description 26
- 238000006243 chemical reaction Methods 0.000 claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229920000578 graft copolymer Polymers 0.000 claims abstract description 17
- 239000011541 reaction mixture Substances 0.000 claims abstract description 17
- 229960002989 glutamic acid Drugs 0.000 claims abstract description 14
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 13
- 239000008367 deionised water Substances 0.000 claims abstract description 11
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 11
- 239000012153 distilled water Substances 0.000 claims abstract description 8
- 239000000047 product Substances 0.000 claims description 22
- 239000002244 precipitate Substances 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 9
- 238000001291 vacuum drying Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 2
- 238000010189 synthetic method Methods 0.000 claims description 2
- 150000008065 acid anhydrides Chemical class 0.000 claims 1
- 230000035484 reaction time Effects 0.000 claims 1
- 238000001308 synthesis method Methods 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-Glutamic acid Natural products OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract description 16
- 239000003814 drug Substances 0.000 abstract description 14
- 229940079593 drug Drugs 0.000 abstract description 13
- BGGHCRNCRWQABU-JTQLQIEISA-N (2s)-2-amino-5-oxo-5-phenylmethoxypentanoic acid Chemical compound OC(=O)[C@@H](N)CCC(=O)OCC1=CC=CC=C1 BGGHCRNCRWQABU-JTQLQIEISA-N 0.000 abstract description 12
- 230000002209 hydrophobic effect Effects 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 238000013270 controlled release Methods 0.000 abstract description 3
- 238000012377 drug delivery Methods 0.000 abstract description 3
- 229920002643 polyglutamic acid Polymers 0.000 abstract description 3
- 230000002194 synthesizing effect Effects 0.000 abstract description 3
- 238000006065 biodegradation reaction Methods 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- 230000009102 absorption Effects 0.000 description 16
- 238000010521 absorption reaction Methods 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 239000000693 micelle Substances 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 238000005481 NMR spectroscopy Methods 0.000 description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- 239000012043 crude product Substances 0.000 description 10
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 9
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 9
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- 238000004566 IR spectroscopy Methods 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000000967 suction filtration Methods 0.000 description 7
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 6
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 239000013078 crystal Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 235000019445 benzyl alcohol Nutrition 0.000 description 3
- 238000003760 magnetic stirring Methods 0.000 description 3
- 238000002390 rotary evaporation Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229920001308 poly(aminoacid) Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- RFWFOJDAIRDAPK-VKHMYHEASA-N (3s)-3-aminooxane-2,6-dione Chemical compound N[C@H]1CCC(=O)OC1=O RFWFOJDAIRDAPK-VKHMYHEASA-N 0.000 description 1
- HFZKKJHBHCZXTQ-JTQLQIEISA-N (4s)-4-azaniumyl-5-oxo-5-phenylmethoxypentanoate Chemical compound OC(=O)CC[C@H](N)C(=O)OCC1=CC=CC=C1 HFZKKJHBHCZXTQ-JTQLQIEISA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000007098 aminolysis reaction Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000013267 controlled drug release Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- DHQUQYYPAWHGAR-UHFFFAOYSA-N dibenzyl 2-aminopentanedioate Chemical compound C=1C=CC=CC=1COC(=O)C(N)CCC(=O)OCC1=CC=CC=C1 DHQUQYYPAWHGAR-UHFFFAOYSA-N 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
Images
Landscapes
- Polyamides (AREA)
Abstract
本发明涉及一种合成β-环糊精-聚L-谷氨酸-苄酯接枝共聚物的方法。一定量的氨基β-环糊精、γ-苄酯L-谷氨酸环内酸酐,在N,N-二甲基甲酰胺中混合后,在反应温度25℃、氮气保护下反应60~80h,反应混合物倒入去离子水中沉淀,用蒸馏水洗涤沉淀,在100℃真空干燥得目标产物。本发明改善了聚L-谷氨酸的水溶性,同时疏水性聚L-谷氨酸-苄酯链段能够调节亲水性β-环糊精的生物降解速度及周期,通过改变各链段的含量得到能控制溶解性和降解性的共聚物。本发明的共聚物能够把疏水性药物分子组装到其疏水的核中,具有提高药物在血液中的循环时间等作用,在药物的控制释放和靶向药物传递等生物医用领域具有很好的应用前景。The invention relates to a method for synthesizing β-cyclodextrin-poly L-glutamic acid-benzyl ester graft copolymer. A certain amount of amino β-cyclodextrin and γ-benzyl ester L-glutamic acid cyclic anhydride are mixed in N,N-dimethylformamide and reacted at a reaction temperature of 25°C under nitrogen protection for 60-80 hours , the reaction mixture was poured into deionized water to precipitate, washed with distilled water, and dried in vacuum at 100°C to obtain the target product. The invention improves the water solubility of poly-L-glutamic acid, and at the same time, the hydrophobic poly-L-glutamic acid-benzyl ester segment can regulate the biodegradation speed and cycle of hydrophilic β-cyclodextrin, by changing each segment The content of the copolymer can control the solubility and degradability. The copolymer of the present invention can assemble hydrophobic drug molecules into its hydrophobic core, has the effect of improving the circulation time of drugs in the blood, and has good applications in biomedical fields such as controlled release of drugs and targeted drug delivery. prospect.
Description
技术领域:本发明涉及一种合成β-环糊精-聚氨基酸接枝共聚物的方法,特别涉及一种以L-谷氨酸与β-环糊精合成β-环糊精-聚L-谷氨酸-苄酯接枝共聚物的方法。Technical field: The present invention relates to a method for synthesizing β-cyclodextrin-polyamino acid graft copolymer, in particular to a method for synthesizing β-cyclodextrin-poly-L- Method of glutamic acid-benzyl ester graft copolymer.
背景技术:聚氨基酸是一类具有低毒、生物相容性好、容易被机体吸收、代谢等优点的生物降解高分子,因此在医学领域如药物控释、组织工程等方面具有广泛的应用。但是其均聚物的水溶性较差,其应用具有一定的局限性。Background technology: Polyamino acids are a class of biodegradable polymers with low toxicity, good biocompatibility, and easy absorption and metabolism by the body. Therefore, they are widely used in medical fields such as controlled drug release and tissue engineering. However, the water solubility of its homopolymer is poor, and its application has certain limitations.
β-环糊精(β-Cyclodextrin,简称β-CD)是由淀粉经发酵生成的,由七个D-(+)-吡喃葡萄糖组成,其每个葡萄糖都取椅式构象,通过α-1,4-苷键首尾相接形成一个环状分子,具有一个略呈截锥形的圆筒结构。β-cyclodextrin (β-Cyclodextrin, referred to as β-CD) is produced by fermentation of starch and consists of seven D-(+)-glucopyranose, each of which takes a chair conformation, through α- The 1,4-glycosidic linkages connect end to end to form a ring-shaped molecule with a slightly truncated cone-shaped cylindrical structure.
β-CD分子外侧因布满了羟基而显亲水性,其锥形圆筒内侧有两圈碳原子上的氢原子,碳氢键中间夹着一圈缩醛氧原子(醚环)结构,具有较强的疏水性,能包结多种客体分子,具有分子囊的美称。β-CD具有良好的生物相容性,在医药、食品等很多领域都得到广泛应用。比如可以对疏水性药物进行包结,提高药物的稳定性和溶解性,延长药物效力,提高药物利用率。综上所述,将β-环糊精与疏水的聚氨基酸进行共聚,能够改善聚氨基酸的水溶性,得到具有特殊性质的新型两亲高分子,有关内容未见文献报导。The outer side of the β-CD molecule is hydrophilic because it is covered with hydroxyl groups. There are two rings of hydrogen atoms on carbon atoms inside the conical cylinder, and a ring of acetal oxygen atoms (ether rings) in the middle of the carbon-hydrogen bond. It has strong hydrophobicity, can contain various guest molecules, and has the reputation of molecular capsule. β-CD has good biocompatibility and has been widely used in many fields such as medicine and food. For example, hydrophobic drugs can be included to improve drug stability and solubility, prolong drug efficacy, and improve drug utilization. To sum up, the copolymerization of β-cyclodextrin and hydrophobic polyamino acid can improve the water solubility of polyamino acid, and obtain a new type of amphiphilic polymer with special properties, and the related content has not been reported in the literature.
发明内容:本发明的目的是为了克服聚氨基酸在水中溶解性较差的缺点,将其与水溶性良好的β-环糊精制成共聚物,从而得到通过改变各链段的含量来得到能控制溶解性的共聚物。Summary of the invention: The purpose of the present invention is to overcome the disadvantage of poor solubility of polyamino acid in water, and make it into a copolymer with β-cyclodextrin with good water solubility, so as to obtain energy by changing the content of each chain segment. Solubility controlled copolymer.
作为骨架的β-环糊精的结构式:Structural formula of β-cyclodextrin as backbone:
作为接枝链的聚氨基酸的结构式:Structural formula of polyamino acids as grafted chains:
其中,R为:Among them, R is:
为了实现上述目的,本发明提供一种β-环糊精-聚L-谷氨酸-苄酯接枝共聚物的合成方法,其特征在于一定量的氨基β-环糊精、γ-苄酯L-谷氨酸环内酸酐(NCA)在N,N-二甲基甲酰胺(DMF)中混合后,在反应温度25℃、氮气保护下搅拌反应60~80h,反应混合物倒入去离子水中沉淀,抽滤,用蒸馏水洗涤沉淀,在100℃真空干燥得目标产物。其中:In order to achieve the above object, the present invention provides a synthetic method of β-cyclodextrin-poly L-glutamic acid-benzyl ester graft copolymer, which is characterized in that a certain amount of amino β-cyclodextrin, γ-benzyl ester After mixing L-glutamic acid anhydride (NCA) in N,N-dimethylformamide (DMF), stir the reaction at a reaction temperature of 25°C under nitrogen protection for 60-80 hours, and pour the reaction mixture into deionized water Precipitate, filter with suction, wash the precipitate with distilled water, and dry under vacuum at 100°C to obtain the target product. in:
β-环糊精与氨基酸环内酸酐(NCA)的摩尔比为1:10~70;The molar ratio of β-cyclodextrin to amino acid anhydride (NCA) is 1:10~70;
每克γ-苄酯-L-谷氨酸环内酸酐所用N,N-二甲基甲酰胺为70~80mL;The N,N-dimethylformamide used per gram of γ-benzyl ester-L-glutamic acid anhydride is 70-80mL;
N,N-二甲基甲酰胺与去离子水的体积比为1:3~5The volume ratio of N,N-dimethylformamide to deionized water is 1:3~5
本发明的反应机理是:先由β-环糊精与对甲基苯磺酰氯经过酯化反应制得甲苯磺酰基β-环糊精;再经叠氮化反应制得叠氮化β-环糊精;最后经氨解反应制得氨基化β-环糊精;L-谷氨酸与苯甲醇经酯化反应制得L-谷氨酸-苄酯,再与固体光气经环化反应制得γ-苄酯-L-谷氨酸环内酸酐(NCA);最后,氨基β-环糊精分子中的NH2基进攻NCA单体的5位羰基碳原子,形成中间体A,该中间体迅速消去CO2后生成中间体B,然后B再继续和NCA单体反应形成接枝共聚物。The reaction mechanism of the present invention is as follows: first, tosyl β-cyclodextrin is obtained through esterification reaction of β-cyclodextrin and p-toluenesulfonyl chloride; Dextrin; finally, ammonized β-cyclodextrin is obtained by aminolysis reaction; L-glutamic acid-benzyl ester is obtained by esterification of L-glutamic acid and benzyl alcohol, and then cyclized with solid phosgene Obtain γ-benzyl ester-L-glutamic acid anhydride (NCA); finally, the NH group in the amino β-cyclodextrin molecule attacks the 5-carbonyl carbon atom of the NCA monomer to form intermediate A, which The intermediate quickly eliminates CO 2 to generate intermediate B, and then B continues to react with NCA monomer to form a graft copolymer.
发明人通过实验室试验,合成了β-环糊精-聚氨基酸接枝共聚物,并通过红外光谱和核磁共振等确认产物。The inventor synthesized the β-cyclodextrin-polyamino acid graft copolymer through laboratory experiments, and confirmed the product through infrared spectroscopy and nuclear magnetic resonance.
实验例1Experimental example 1
材料:L-谷氨酸(AR,国药集团化学试剂有限公司)Material: L-glutamic acid (AR, Sinopharm Chemical Reagent Co., Ltd.)
苯甲醇(AR,国药集团化学试剂有限公司)Benzyl alcohol (AR, Sinopharm Chemical Reagent Co., Ltd.)
固体光气(AR,海宁中联化学有限公司)Solid phosgene (AR, Haining Zhonglian Chemical Co., Ltd.)
β-环糊精(AR,国药集团化学试剂有限公司)β-cyclodextrin (AR, Sinopharm Chemical Reagent Co., Ltd.)
对甲基苯磺酰氯(AR,国药集团化学试剂有限公司)p-Toluenesulfonyl chloride (AR, Sinopharm Chemical Reagent Co., Ltd.)
叠氮钠(AR,国药集团化学试剂有限公司)Sodium azide (AR, Sinopharm Chemical Reagent Co., Ltd.)
N,N-二甲基甲酰胺(DMF)(AR,国药集团化学试剂有限公司)N, N-Dimethylformamide (DMF) (AR, Sinopharm Chemical Reagent Co., Ltd.)
三苯基膦(AR,国药集团化学试剂有限公司)Triphenylphosphine (AR, Sinopharm Chemical Reagent Co., Ltd.)
吡啶(AR,国药集团化学试剂有限公司)Pyridine (AR, Sinopharm Chemical Reagent Co., Ltd.)
碘化钾(AR,国药集团化学试剂有限公司)Potassium iodide (AR, Sinopharm Chemical Reagent Co., Ltd.)
仪器:PE Spectrum one傅立叶变换红外光谱仪Instrument: PE Spectrum one Fourier transform infrared spectrometer
Varian XL-300核磁共振谱仪Varian XL-300 NMR spectrometer
MalvernNano ZS纳米粒度及Zeta电位分析仪MalvernNano ZS Nanoparticle Size and Zeta Potential Analyzer
(一)L-谷氨酸-苄酯的合成:(1) Synthesis of L-glutamic acid-benzyl ester:
称取11.1g L-谷氨酸于250mL三口瓶中,加入53mL苯甲醇和18mL氢溴酸。然后在磁搅拌下缓慢加热,反应温度控制在70℃左右,待L-谷氨酸全部溶解后(时间约1h),将反应混合液冷却到30℃,然后倒入由22mL吡啶和147mL 95%乙醇配制的混合溶液中,3℃下放置12h,使其充分沉淀。抽滤,沉淀分别用30mL乙醇和30mL乙醚洗涤,所得白色固体即为粗产物。粗产物用5%的乙醇重结晶,50℃真空干燥得产物5.658g,产率31.6%,产物熔点为172~174℃。Weigh 11.1g of L-glutamic acid into a 250mL three-neck flask, add 53mL of benzyl alcohol and 18mL of hydrobromic acid. Then heat slowly under magnetic stirring, and the reaction temperature is controlled at about 70°C. After the L-glutamic acid is completely dissolved (about 1h), the reaction mixture is cooled to 30°C, and then poured into a mixture of 22mL pyridine and 147mL 95% In the mixed solution prepared by ethanol, place it at 3°C for 12 hours to make it fully precipitate. After suction filtration, the precipitate was washed with 30 mL of ethanol and 30 mL of ether, respectively, and the obtained white solid was the crude product. The crude product was recrystallized with 5% ethanol and dried under vacuum at 50°C to obtain 5.658g of product with a yield of 31.6%. The melting point of the product was 172-174°C.
(二)γ-苄酯-L-谷氨酸环内酸酐的合成:(2) Synthesis of γ-benzyl ester-L-glutamic acid anhydride in the ring:
称取5.658g新鲜制备的L-谷氨酸-苄酯于装有回流冷凝管、温度计和碱吸收装置的250mL三口瓶中,再加入75mL无水四氢呋喃,升温至50℃,磁搅拌下加入8.5g固体光气。待反应悬浊液变澄清后(约40min),通氮气30min,以除去反应生成的氯化氢和剩余的光气。反应混合液旋转蒸发除去部分四氢呋喃,冷却至室温后倒入150mL石油醚中,在-20℃放置12h,抽滤得白色针状晶体为粗产物。粗产物用30mL四氢呋喃溶解、过滤,滤液倒入70mL石油醚中得沉淀。沉淀过滤,自然干燥后得白色针状晶体3.332g,即为产物。产率53.1%,熔点为95~96℃。反应式如下:Weigh 5.658g of freshly prepared L-glutamic acid-benzyl ester into a 250mL three-necked flask equipped with a reflux condenser, a thermometer and an alkali absorption device, then add 75mL of anhydrous tetrahydrofuran, raise the temperature to 50°C, and add 8.5 g solid phosgene. After the reaction suspension became clear (about 40 min), nitrogen gas was passed for 30 min to remove the hydrogen chloride and remaining phosgene generated by the reaction. Part of the tetrahydrofuran was removed by rotary evaporation of the reaction mixture, cooled to room temperature, poured into 150 mL of petroleum ether, placed at -20°C for 12 h, and white needle-like crystals were obtained by suction filtration as the crude product. The crude product was dissolved in 30 mL of tetrahydrofuran, filtered, and the filtrate was poured into 70 mL of petroleum ether to obtain a precipitate. The precipitate was filtered, and after natural drying, 3.332 g of white needle-like crystals were obtained, which was the product. The yield is 53.1%, and the melting point is 95-96°C. The reaction formula is as follows:
(三)氨基β-环糊精的合成:(3) Synthesis of amino β-cyclodextrin:
将10gβ-环糊精、2.5g对甲基苯磺酰氯和140mL吡啶加入250mL三口瓶中,氮气保护下,控制反应温度40℃搅拌反应4h。用旋转蒸发仪浓缩反应混合液,然后倒入100mL丙酮中沉淀,待沉淀完全后抽滤,用丙酮洗涤沉淀,50℃真空干燥得5.454g白色粉末即为甲苯磺酰基β-环糊精,产率48.6%。Add 10g of β-cyclodextrin, 2.5g of p-toluenesulfonyl chloride and 140mL of pyridine into a 250mL three-necked flask, and under nitrogen protection, control the reaction temperature at 40°C and stir for 4h. Concentrate the reaction mixture with a rotary evaporator, then pour it into 100 mL of acetone for precipitation, filter it with suction after the precipitation is complete, wash the precipitate with acetone, and dry it in vacuum at 50°C to obtain 5.454 g of white powder, which is tosyl β-cyclodextrin. rate of 48.6%.
将5.454g甲苯磺酰基β-环糊精、2.00g叠氮钠、0.20g碘化钾和40mL DMF加入250mL三口瓶中,氮气保护下,控制反应温度80℃搅拌反应24h。将反应混合液中的DMF蒸干,加入100mL去离子水溶解粗产物,然后将其倒入300mL乙醇中沉淀,抽滤,50℃真空干燥得叠氮化β-环糊精4.060g,产率77.6%。Add 5.454g of tosyl β-cyclodextrin, 2.00g of sodium azide, 0.20g of potassium iodide and 40mL of DMF into a 250mL three-neck flask, under nitrogen protection, control the reaction temperature at 80°C and stir for 24h. The DMF in the reaction mixture was evaporated to dryness, 100 mL of deionized water was added to dissolve the crude product, and then it was poured into 300 mL of ethanol to precipitate, filtered with suction, and dried in vacuum at 50°C to obtain 4.060 g of azide β-cyclodextrin, the yield 77.6%.
将4.060g叠氮基化β-环糊精的,1.80g三苯基膦,80mLDMF,15mL氨水加入反应器中,氮气保护下,在40℃搅拌反应24h。反应混合液倒入200mL丙酮中沉淀,抽滤,50℃真空干燥得氨基化β-环糊精3.568g,产率87.9%。产物经红外光谱和核磁共振等确认。反应式如下:Add 4.060g of azidolated β-cyclodextrin, 1.80g of triphenylphosphine, 80mL of DMF, and 15mL of ammonia water into the reactor, and stir and react at 40°C for 24h under the protection of nitrogen. The reaction mixture was poured into 200 mL of acetone for precipitation, suction filtered, and vacuum-dried at 50° C. to obtain 3.568 g of aminated β-cyclodextrin, with a yield of 87.9%. The product was confirmed by infrared spectroscopy and nuclear magnetic resonance. The reaction formula is as follows:
(四)β-环糊精-聚L-谷氨酸-苄酯接枝共聚物(β-CDPBLG1)的合成:(4) Synthesis of β-cyclodextrin-poly L-glutamic acid-benzyl ester graft copolymer (β-CDPBLG1):
将0.431g(0.38mmol)氨基β-环糊精和1.0g(3.8mmol)γ-苄酯L-谷氨酸环内酸酐放入反应瓶中,加入75mL无水DMF,在25℃,氮气保护下搅拌反应72h。将反应混合液倒入300mL去离子水中得到沉淀。抽滤,用蒸馏水洗涤沉淀,100℃真空干燥得目标产物,产率43.6%。反应式如下:Put 0.431g (0.38mmol) of amino β-cyclodextrin and 1.0g (3.8mmol) of γ-benzyl L-glutamic acid cyclic anhydride into the reaction flask, add 75mL of anhydrous DMF, at 25°C, nitrogen protection The reaction was stirred for 72h. The reaction mixture was poured into 300 mL deionized water to obtain a precipitate. Suction filtration, washing the precipitate with distilled water, and vacuum drying at 100°C gave the target product with a yield of 43.6%. The reaction formula is as follows:
通过红外光谱、核磁共振等确认产物。在IR谱图中,600cm-1~800cm-1处的两个特征吸收为聚L-谷氨酸-苄酯链段中苯环的特征吸收;1600cm-1和1500cm-1处的两个吸收峰为聚L-谷氨酸-苄酯链段中酰胺键的两个特征吸收;通常称为酰胺I带和酰胺II带;1700cm-1处的吸收峰为苄酯中酯键上羰基的特征吸收;3200cm-1左右的吸收峰为β-环糊精中羟基和聚L-谷氨酸-苄酯中氨基的特征吸收。在谱图中可以观察到β-环糊精和聚L-谷氨酸苄酯两个链段的特征吸收,而NCA分子中两个羰基在1855cm-1和1785cm-1处的吸收峰消失,初步说明形成了共聚物。The product was confirmed by infrared spectroscopy, nuclear magnetic resonance and the like. In the IR spectrum, the two characteristic absorptions at 600cm -1 ~ 800cm -1 are the characteristic absorptions of the benzene ring in the poly L-glutamic acid-benzyl ester segment; the two absorptions at 1600cm -1 and 1500cm -1 The peaks are two characteristic absorptions of the amide bond in the poly-L-glutamic acid-benzyl ester segment; commonly referred to as the amide I band and the amide II band; the absorption peak at 1700 cm is characteristic of the carbonyl group on the ester bond in the benzyl ester Absorption: The absorption peak around 3200cm -1 is the characteristic absorption of the hydroxyl group in β-cyclodextrin and the amino group in poly-L-glutamic acid-benzyl ester. In the spectrogram, the characteristic absorption of the two segments of β-cyclodextrin and poly-benzyl glutamate can be observed, while the absorption peaks of the two carbonyl groups in the NCA molecule at 1855cm -1 and 1785cm -1 disappear, Preliminary indications were that a copolymer was formed.
在1H NMR谱图中,δ=7.2ppm左右是聚L-谷氨酸-苄酯链段上苯环上H的化学位移;δ=5.0ppm左右是苄基中亚甲基(CH2)上H的化学位移;δ=2.4ppm处的吸收峰是聚L-谷氨酸苄酯中-CH2CH2-基团上H的化学位移;δ=3.9处是聚L-谷氨酸苄酯链段中次甲基(CH)H的化学位移;;δ=8.0ppm左右是聚L-谷氨酸苄酯链段中NH上H的化学位移;δ=3.3~3.6ppm处的吸收峰是β-环糊精分子中2,3,4,5,6位H的化学位移;δ=4.8ppm的吸收峰是β-环糊精分子中1位H的化学位移。从聚合物的核磁谱图可以看出,β-环糊精链段和聚L-谷氨酸苄酯链段中相应基团的特征峰都存在。综合IR和1H NMR分析,可以确认产物是β-环糊精—聚L-谷氨酸-苄酯接枝共聚物。In the 1 H NMR spectrum, about δ=7.2ppm is the chemical shift of H on the benzene ring on the poly-L-glutamic acid-benzyl ester segment; about δ=5.0ppm is the methylene group (CH 2 ) in the benzyl group The chemical shift of H on the top; the absorption peak at δ=2.4ppm is the chemical shift of H on the -CH 2 CH 2 -group in poly-L-glutamic acid benzyl ester; δ=3.9 is poly-L-glutamic acid benzyl The chemical shift of methine (CH)H in the ester segment; δ=8.0ppm is the chemical shift of H on the NH in the poly-L-benzyl glutamate segment; the absorption peak at δ=3.3~3.6ppm is the chemical shift of H at
本发明的有益效果是:通过本发明实现了β-环糊精与疏水的聚氨基酸(聚L-谷氨酸-苄酯)共聚,得到了具有特殊性质的具有两亲结构的新型β-环糊精-聚L-谷氨酸-苄酯接枝共聚物。这种共聚物不仅能够改善聚L-谷氨酸-苄酯的水溶性,同时疏水性聚L-谷氨酸-苄酯链段也能够调节亲水性β-环糊精的生物降解速度及周期,因此通过改变各链段的含量来得到能控制溶解性和降解性的共聚物。本发明制备的β-环糊精—聚L-谷氨酸-苄酯接枝共聚物是一种两亲性共聚物,能够在水溶液中自组装形成内核疏水、外壳亲水胶束。这种共聚物胶束能够把疏水性药物分子组装到其疏水的核中,具有提高药物在血液中的循环时间等作用,在药物的控制释放和靶向药物传递等生物医用领域具有很好的应用前景。The beneficial effects of the present invention are: through the present invention, the copolymerization of β-cyclodextrin and hydrophobic polyamino acid (poly-L-glutamic acid-benzyl ester) is realized, and a novel β-cyclodextrin with amphiphilic structure with special properties is obtained. Dextrin-poly-L-glutamic acid-benzyl ester graft copolymer. This copolymer can not only improve the water solubility of poly-L-glutamic acid-benzyl ester, but also the hydrophobic poly-L-glutamic acid-benzyl ester segment can also regulate the biodegradation rate and Period, so by changing the content of each segment to obtain a copolymer that can control solubility and degradability. The β-cyclodextrin-poly L-glutamic acid-benzyl ester graft copolymer prepared by the invention is an amphiphilic copolymer, which can self-assemble in aqueous solution to form micelles with a hydrophobic inner core and a hydrophilic outer shell. This copolymer micelle can assemble hydrophobic drug molecules into its hydrophobic core, which has the effect of improving the circulation time of drugs in the blood, and has good applications in biomedical fields such as controlled release of drugs and targeted drug delivery. Application prospects.
附图说明: Description of drawings:
图1是实验例1中合成的β-CDPBLG1形成的胶束粒径分布图;Fig. 1 is the micelle particle size distribution figure that the synthetic β-CDPBLG1 in Experimental Example 1 forms;
图2是实施例4中合成的β-CDPBLG2形成的胶束粒径分布图;Fig. 2 is the micelle size distribution figure that the synthetic β-CDPBLG2 in embodiment 4 forms;
图3是实施例5中合成的β-CDPBLG3形成的胶束粒径分布图。FIG. 3 is a particle size distribution diagram of micelles formed by β-CDPBLG3 synthesized in Example 5. FIG.
具体实施方式: Detailed ways:
实施例1L-谷氨酸-苄酯的合成:The synthesis of embodiment 1L-glutamic acid-benzyl ester:
称取11.1g L-谷氨酸于250mL三口瓶中,加入53mL苯甲醇和18mL氢溴酸。然后在磁搅拌下缓慢加热,反应温度控制在70℃左右,待L-谷氨酸全部溶解后(时间约1h),将反应混合液冷却到30℃,然后倒入由22mL吡啶和147mL95%乙醇配制的混合溶液中,3℃下放置12h,使其充分沉淀。将沉淀抽滤,分别用30mL乙醇和30mL乙醚洗涤沉淀,所得白色固体即为粗产物。粗产物用5%的乙醇重结晶,50℃真空干燥得产物5.658g,产率31.6%,产物熔点为172~174℃。Weigh 11.1g of L-glutamic acid into a 250mL three-neck flask, add 53mL of benzyl alcohol and 18mL of hydrobromic acid. Then heat slowly under magnetic stirring, and the reaction temperature is controlled at about 70°C. After the L-glutamic acid is completely dissolved (about 1h), the reaction mixture is cooled to 30°C, and then poured into a mixture of 22mL pyridine and 147mL95% ethanol In the prepared mixed solution, place it at 3°C for 12 hours to allow it to fully precipitate. The precipitate was suction-filtered, washed with 30 mL ethanol and 30 mL ether, respectively, and the obtained white solid was the crude product. The crude product was recrystallized with 5% ethanol and dried under vacuum at 50°C to obtain 5.658g of product with a yield of 31.6%. The melting point of the product was 172-174°C.
实施例2 γ-苄酯L-谷氨酸环内酸酐的合成:Synthesis of anhydride in the ring of
称取5.658g新鲜制备的L-谷氨酸-苄酯于250mL三口瓶中,三口瓶装有回流冷凝管,温度计,碱吸收装置。加入75mL无水四氢呋喃,升温至50℃,磁搅拌下加入8.5g固体光气,待反应悬浊液变澄清后(约40min),通氮气30min,以除去反应生成的氯化氢和剩余的光气。反应混合液旋转蒸发除去部分四氢呋喃,冷却至室温后倒入150mL石油醚中,在-20℃放置12h,抽滤得白色针状晶体为粗产物。粗产物用30mL四氢呋喃溶解、过滤,滤液倒入70mL石油醚中得沉淀。沉淀过滤,自然干燥后得白色针状晶体3.332g,即为产物。产率53.1%,熔点为95~96℃,产物经红外光谱和核磁共振等确认。Weigh 5.658g of freshly prepared L-glutamic acid-benzyl ester into a 250mL three-necked flask, which is equipped with a reflux condenser, a thermometer, and an alkali absorption device. Add 75mL of anhydrous tetrahydrofuran, raise the temperature to 50°C, add 8.5g of solid phosgene under magnetic stirring, and after the reaction suspension becomes clear (about 40min), pass nitrogen gas for 30min to remove the hydrogen chloride and remaining phosgene generated by the reaction. Part of the tetrahydrofuran was removed by rotary evaporation of the reaction mixture, cooled to room temperature, poured into 150 mL of petroleum ether, placed at -20°C for 12 h, and white needle-like crystals were obtained by suction filtration as the crude product. The crude product was dissolved in 30 mL of tetrahydrofuran, filtered, and the filtrate was poured into 70 mL of petroleum ether to obtain a precipitate. The precipitate was filtered, and after natural drying, 3.332 g of white needle-like crystals were obtained, which was the product. The yield is 53.1%, and the melting point is 95-96°C. The product is confirmed by infrared spectrum and nuclear magnetic resonance.
实施例3 氨基β-环糊精的合成:Embodiment 3 The synthesis of amino β-cyclodextrin:
将10gβ-环糊精、2.5g对甲基苯磺酰氯和140mL吡啶加入250mL三口瓶中,氮气保护下,在40℃搅拌反应4h。用旋转蒸发仪浓缩反应混合液,然后倒入100mL丙酮中沉淀,待沉淀完全后抽滤,用丙酮洗涤沉淀,50℃真空干燥得白色粉末即为氨基β-环糊精,产物重5.454g,产率48.6%。Add 10g of β-cyclodextrin, 2.5g of p-toluenesulfonyl chloride and 140mL of pyridine into a 250mL three-necked flask, and stir at 40°C for 4h under nitrogen protection. Concentrate the reaction mixture with a rotary evaporator, then pour it into 100mL of acetone to precipitate, filter it with suction after the precipitation is complete, wash the precipitate with acetone, and dry it in vacuum at 50°C to obtain a white powder, which is aminoβ-cyclodextrin, with a product weight of 5.454g. Yield 48.6%.
将5.454g甲苯磺酰基β-环糊精、2.00g叠氮钠、0.20g碘化钾和40mL DMF加入250mL三口瓶中,在80℃、氮气保护下搅拌反应24h。将反应混合液中的DMF蒸干,加入100mL去离子水溶解粗产物,用300mL乙醇沉淀,抽滤,50℃真空干燥得叠氮化β-环糊精4.060g,产率77.6%。Add 5.454g of tosyl β-cyclodextrin, 2.00g of sodium azide, 0.20g of potassium iodide and 40mL of DMF into a 250mL three-necked flask, and stir and react at 80°C for 24h under nitrogen protection. The DMF in the reaction mixture was evaporated to dryness, 100 mL of deionized water was added to dissolve the crude product, precipitated with 300 mL of ethanol, filtered with suction, and dried under vacuum at 50°C to obtain 4.060 g of azide β-cyclodextrin with a yield of 77.6%.
将4.060g叠氮化β-环糊精的、1.80g三苯基膦、80mL DMF和15mL氨水加入反应瓶中,在40℃、氮气保护下搅拌反应24h。反应混合倒入200mL丙酮中沉淀,抽滤,50℃真空干燥得氨基化β-环糊精3.568g,产率87.9%。产物经红外光谱和核磁共振等确认。Add 4.060g of β-cyclodextrin azide, 1.80g of triphenylphosphine, 80mL of DMF and 15mL of ammonia water into the reaction flask, and stir and react at 40°C for 24h under the protection of nitrogen. The reaction mixture was poured into 200 mL of acetone for precipitation, suction filtered, and vacuum-dried at 50° C. to obtain 3.568 g of aminated β-cyclodextrin, with a yield of 87.9%. The product was confirmed by infrared spectroscopy and nuclear magnetic resonance.
实施例4β-环糊精-聚L-谷氨酸苄酯接枝共聚物(β-CDPBLG2)的合成:The synthesis of embodiment 4β-cyclodextrin-poly-L-benzyl glutamate graft copolymer (β-CDPBLG2):
将0.144g(0.127mmol)氨基β-环糊精和1.0g(3.8mmol)γ-苄酯L-谷氨酸环内酸酐放入反应瓶中,加入75mL无水DMF,在25℃、氮气保护下搅拌反应72h。将反应混合液倒入300mL去离子水中得到沉淀。抽滤,用蒸馏水洗涤沉淀,100℃真空干燥得目标产物,产率40.34%。产物经红外光谱和核磁共振等确认。Put 0.144g (0.127mmol) of amino β-cyclodextrin and 1.0g (3.8mmol) of γ-benzyl L-glutamic acid cyclic anhydride into the reaction flask, add 75mL of anhydrous DMF, at 25 ℃, nitrogen protection The reaction was stirred for 72h. The reaction mixture was poured into 300 mL deionized water to obtain a precipitate. Suction filtration, washing the precipitate with distilled water, and vacuum drying at 100°C gave the target product with a yield of 40.34%. The product was confirmed by infrared spectroscopy and nuclear magnetic resonance.
实施例5 β-环糊精-聚L-谷氨酸-苄酯接枝共聚物(β-CDPBLG3)的合成:Example 5 Synthesis of β-cyclodextrin-poly-L-glutamic acid-benzyl ester graft copolymer (β-CDPBLG3):
将0.086g(0.0758mmol)氨基β-环糊精和1.0g(3.8mmol)γ-苄酯L-谷氨酸环内酸酐放入反应瓶中,加入80mL无水DMF,在25℃、氮气保护下搅拌反应60h。将反应混合液倒入400mL去离子水中得到沉淀。抽滤,用蒸馏水洗涤沉淀,100℃真空干燥得目标产物,产率34.2%。产物经红外光谱和核磁共振等确认。Put 0.086g (0.0758mmol) of amino β-cyclodextrin and 1.0g (3.8mmol) of γ-benzyl ester L-glutamic acid cyclic anhydride into the reaction flask, add 80mL of anhydrous DMF, at 25 ℃, nitrogen protection The reaction was stirred for 60h. The reaction mixture was poured into 400 mL deionized water to obtain a precipitate. Suction filtration, washing the precipitate with distilled water, and vacuum drying at 100°C gave the target product with a yield of 34.2%. The product was confirmed by infrared spectroscopy and nuclear magnetic resonance.
实施例6 β-环糊精-聚L-谷氨酸-苄酯接枝共聚物(β-CDPBLG4)的合成:
将0.062g(0.0547mol)氨基β-环糊精和1.0g(3.8mmol)γ-苄酯L-谷氨酸环内酸酐放入反应瓶中,加入70mL无水DMF,在25℃、氮气保护下搅拌反应80h。将反应混合液倒入210mL去离子水中得到沉淀。抽滤,用蒸馏水洗涤沉淀,100℃真空干燥得目标产物,产率18.31%。产物经红外光谱和核磁共振等确认。Put 0.062g (0.0547mol) of amino β-cyclodextrin and 1.0g (3.8mmol) of γ-benzyl L-glutamic acid cyclic anhydride into the reaction flask, add 70mL of anhydrous DMF, at 25 ℃, nitrogen protection The reaction was stirred for 80h. The reaction mixture was poured into 210 mL of deionized water to obtain a precipitate. Suction filtration, washing the precipitate with distilled water, and vacuum drying at 100°C gave the target product with a yield of 18.31%. The product was confirmed by infrared spectroscopy and nuclear magnetic resonance.
实施例7 胶束的制备:The preparation of embodiment 7 micelles:
分别称取0.05gβ-CDPBLG1、β-CDPBLG2、β-CDPBLG3接枝共聚物分别溶于5mL四氢呋喃中,待完全溶解后,在搅拌下向该溶液中缓慢加入40mL二次蒸馏水,然后旋转蒸发除去其中的四氢呋喃(约需两小时),将剩余的溶液置于50mL容量瓶中,用二次蒸馏水定容得到一定浓度的胶束溶液,利用纳米粒度仪测定胶束的粒径。Weigh 0.05g of β-CDPBLG1, β-CDPBLG2, and β-CDPBLG3 graft copolymers and dissolve them in 5mL of tetrahydrofuran respectively. After they are completely dissolved, slowly add 40mL of double-distilled water to the solution under stirring, and then remove them by rotary evaporation. Tetrahydrofuran (need about two hours), remaining solution is placed in 50mL volumetric flask, obtains the micelle solution of certain concentration with twice distilled water constant volume, utilizes the particle diameter of micelle to measure micelle.
从实施例4~实施例6中可以看出,随着氨基β-环糊精与氨基酸环内酸酐(NCA)的摩尔比的增加,β-环糊精-聚L-谷氨酸-苄酯接枝共聚物的产率降低,所以最适宜的比例是1:10~50。而且在此比例范围内,在水溶液中,能形成粒径在100nm左右的胶束,经试验,当比例为1:10时,能形成平均粒径为114nm的胶束(附图1),比例为1:30时能形成平均粒径为124nm的胶束(附图2),当比例为1:50时能形成平均粒径为96nm的胶束(附图3)。这类由两亲共聚物形成的胶束能够把疏水性药物分子组装到其疏水的核中,具有提高药物在血液中的循环时间等作用,在药物的控制释放和靶向药物传递等领域具有很好的应用前景。As can be seen from Examples 4 to 6, as the molar ratio of amino β-cyclodextrin to amino acid anhydride (NCA) increases, β-cyclodextrin-poly L-glutamic acid-benzyl ester The yield of graft copolymer decreases, so the most suitable ratio is 1:10~50. And within the range of this ratio, in aqueous solution, micelles with a particle diameter of about 100nm can be formed. After testing, when the ratio is 1:10, micelles with an average particle diameter of 114nm can be formed (accompanying drawing 1). When the ratio is 1:30, micelles with an average particle size of 124nm can be formed (see Figure 2), and when the ratio is 1:50, micelles with an average particle size of 96nm can be formed (Figure 3). This kind of micelles formed by amphiphilic copolymers can assemble hydrophobic drug molecules into its hydrophobic core, which can improve the circulation time of drugs in the blood, and has great potential in the fields of controlled release of drugs and targeted drug delivery. Very good application prospects.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101347363A CN100509862C (en) | 2006-12-13 | 2006-12-13 | Synthesis process of beta-cyclodextrin-poly-L-glutamic acid-benzyl ester grafted copolymer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101347363A CN100509862C (en) | 2006-12-13 | 2006-12-13 | Synthesis process of beta-cyclodextrin-poly-L-glutamic acid-benzyl ester grafted copolymer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1974605A CN1974605A (en) | 2007-06-06 |
CN100509862C true CN100509862C (en) | 2009-07-08 |
Family
ID=38124988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101347363A Expired - Fee Related CN100509862C (en) | 2006-12-13 | 2006-12-13 | Synthesis process of beta-cyclodextrin-poly-L-glutamic acid-benzyl ester grafted copolymer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100509862C (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102834117B (en) * | 2010-02-09 | 2015-11-25 | 阿道恰公司 | Functionalized anion polysaccharide is carried out by least two hydrophobic group entrained by the sept of at least trivalent |
JP2012214450A (en) * | 2011-03-25 | 2012-11-08 | Nippon Soda Co Ltd | Crystal polymorph of benzyl glutamate n-carboxylic anhydride |
CN102731777B (en) * | 2012-07-06 | 2013-12-18 | 辽宁大学 | Synthesis method of poly-benzyl L-glutamate/ethyl polyphosphate block copolymer |
CN104195618A (en) * | 2014-07-31 | 2014-12-10 | 江南大学 | Electro-deposition preparation method of magnesium-based biological nano coating material |
CN104311820B (en) * | 2014-09-24 | 2017-06-20 | 北京化工大学 | A kind of method that degradable medicaments carrier is built based on polysaccharide graft poly-aspartate benzyl ester |
CN105884917B (en) * | 2016-05-20 | 2018-05-25 | 江南大学 | A kind of linear dextrin base liposome and preparation method thereof |
CN106317261A (en) * | 2016-09-13 | 2017-01-11 | 合肥工业大学 | Beta-cyclodextrin based star-shaped polymer and preparation method thereof |
CN108329660B (en) * | 2017-01-20 | 2020-09-29 | 深圳市虹彩新材料科技有限公司 | Beta-cyclodextrin graft and preparation method and application thereof |
-
2006
- 2006-12-13 CN CNB2006101347363A patent/CN100509862C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1974605A (en) | 2007-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100509862C (en) | Synthesis process of beta-cyclodextrin-poly-L-glutamic acid-benzyl ester grafted copolymer | |
Li et al. | Synthesis and characterization of a novel double cross-linked hydrogel based on Diels-Alder click reaction and coordination bonding | |
Ganji et al. | Synthesis and characterization of a new thermosensitive chitosan–PEG diblock copolymer | |
Shekh et al. | Oxidized chitosan modified electrospun scaffolds for controllable release of acyclovir | |
CN102964593B (en) | Block polymer, preparation method thereof and electrically active hydrogel | |
CN108752541B (en) | Amphiphilic block polymer with hypoxia and temperature dual responsiveness and taking azo bond as connecting bond and preparation method thereof | |
CN102702454B (en) | PH response four-arm star block copolymer and preparation method and application thereof | |
Mu et al. | Miktoarm star polymers with poly (N-isopropylacrylamide) or poly (oligo (ethylene glycol) methacrylate) as building blocks: synthesis and comparison of thermally-responsive behaviors | |
CN108752542B (en) | Amphiphilic block polymer with hypoxia and pH dual response using azo bond as connecting bond and preparation method thereof | |
Chen et al. | Synthesis and characterization of water-soluble chitosan grafted with hydrophilic aliphatic polyester | |
CN115417889A (en) | L-4-dihydroxyborophenylalanine-N-carboxylic acid internal anhydride monomer and polyamino acid as well as preparation method and application thereof | |
Deng et al. | Investigation on the properties of methoxy poly (ethylene glycol)/chitosan graft co-polymers | |
CN107286326A (en) | Ratio-type fluorescent imaging polymer nanocarriers that quickly penetrate cell membranes and respond to intracellular environments, and their preparation and application | |
Zhang et al. | Dess-Martin oxidation of hydroxypropyl and hydroxyethyl cellulose, and exploration of their polysaccharide/polypeptide hydrogels | |
CN111848891A (en) | A kind of covalent organic polymer based on 2,4,6-tris(4-formylphenyl)pyrimidine and preparation method thereof | |
WO2023240505A1 (en) | L-4-boronophenylalanine-n-carboxyanhydride monomer and polyamino acid as well as preparation method therefor and use thereof | |
CN108641092B (en) | Preparation method of supramolecular polymer composite micelles based on hydrogen bonding | |
CN110396161A (en) | Hypoxia-responsive micelles with fluorescent properties and preparation method thereof | |
CN1986602B (en) | Synthetic method of polyacrylamide-poly L-glutamic acid-benzyl ester graft copolymer | |
CN102061078B (en) | Polymer nano hydrogel and preparation method thereof | |
Kim et al. | Characterizations of novel poly (aspartic acid) derivatives conjugated with γ-amino butyric acid (GABA) as the bioactive molecule | |
CN112812311B (en) | ROS (reactive oxygen species) -responsive polymer material and preparation method thereof | |
CN112979981B (en) | A kind of synthetic method of cellulose grafted polypeptide brush copolymer | |
Teodorescu et al. | Novel hydrogels from diepoxy‐terminated poly (ethylene glycol) s and aliphatic primary diamines: synthesis and equilibrium swelling studies | |
CN113061254B (en) | Cationic polymer gene vector and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090708 Termination date: 20111213 |